A STABILIZED HSA-FREE LIQUID PHARMACEUTICAL COMPOSITION IS DESCRIBED, WHICH COMPRISES AN INTERFERON (IFN), WHEREIN SAID FORMULATION IS A SOLUTION THAT COMPRISES A BUFFER, A SURFACTANT, AN ISOTONICITY AGENT AND AN ANTIOXIDANT. PREFERABLY THE INTERFERON IS HUMAN RECOMBINANT IFN-BETA.